Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - The "Gabrin Sign"

J Am Acad Dermatol. 2020 May 21;S0190-9622(20)30948-8. doi: 10.1016/j.jaad.2020.05.079. Online ahead of print.

Abstract

No abstract available

Keywords: 5-alpha reductase; COVID-19; Dutasteride; Enzalutamide; Finasteride; SARS-CoV-2; Spironolactone; TMPRSS2; androgen receptor; androgenetic alopecia; anti-androgen therapy; human skin; transmembrane protease serine 2.